Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04445064
Title Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. (HN1901)
Acronym HN1901
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cliniques universitaires Saint-Luc- Universite Catholique de Louvain
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL


No variant requirements are available.